Karen Schwartz

4.5k citations
54 papers · 3.5k indexed · 2 hit papers · h-index 25

Karen Schwartz

50 papers receiving 3.4k citations

Hit Papers

The Tangier disease gene product ABC1 controls the cellu...198420261998201219991984200400600

Peers

Karen Schwartz
Comparison fields: 5 of 117
  • Molecular Biology 1.8k
  • Surgery 1.4k
  • Cardiology and Cardiovascular Medicine 1.3k
  • Oncology 577
  • Cancer Research 437
Replace S Lévy-Toledano with:
S Lévy-Toledano France
Ken A. Lindstedt Finland
Stephan Rust Germany
Vincent Sauzeau France
Michelle Olive United States
Ramendra K. Kundu United States
Muriel Laffargue France
Pascal Bernatchez Canada
Benjamin J. Wilkins United States
S M Prescott United States
Karen Schwartz relative to S Lévy-Toledano France S Lévy-Toledano's profile →
Citations per field
00.5×2.9×
S Lévy-Toledano · 1×
Citations per year

Countries citing papers authored by Karen Schwartz

Since Specialization
Citations

This map shows the geographic impact of Karen Schwartz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karen Schwartz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karen Schwartz more than expected).

Fields of papers citing papers by Karen Schwartz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karen Schwartz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karen Schwartz. The network helps show where Karen Schwartz may publish in the future.

Co-authorship network of co-authors of Karen Schwartz

This figure shows the co-authorship network connecting the top 25 collaborators of Karen Schwartz. A scholar is included among the top collaborators of Karen Schwartz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karen Schwartz. Karen Schwartz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 1
3 3
4 9
5 357
6
The Tangier disease gene product ABC1 controls the cellular apolipoprotein-mediated lipid removal pathwaybreakdown →
611
7 76
8 72
9 76
10 73
11 8
12 162
13 122
14 17
15 383
16 1
17 56
18 33
19
Isozymes of Myosin in Regenerating Rat Muscles
1
20 123

About Karen Schwartz

Karen Schwartz is a scholar working on Cardiology and Cardiovascular Medicine, Conservation and Applied Microbiology and Biotechnology, having authored 54 papers that have together received 3.5k indexed citations. Recurring topics across this work include Cardiomyopathy and Myosin Studies (11 papers), Cardiovascular Effects of Exercise (7 papers) and Nuclear Structure and Function (4 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (1.3k citations), Surgery (1.4k citations) and Cancer Research (437 citations). Karen Schwartz has collaborated with scholars based in United States, France and Hungary. Frequent co-authors include Richard M. Lawn, David P. Wade, Robert M. Rapoport, Ferid Murad, Scott A. Waldman, Raymond J. Winquist, C Wisnewsky, Elizabeth P. Faison, Ashley M. Vaughan and J. Gordon Porter. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026